Oncogenes and tumor suppressor genes: therapeutic implications
- PMID: 10068275
Oncogenes and tumor suppressor genes: therapeutic implications
Abstract
Genetic instability is a hallmark of cancer. Alterations in DNA through mutations, deletions, and translocations affect genes that are fundamental to normal cell growth differentiation and programmed cell death. Here, we discuss these alterations as they relate to oncogenes and tumor suppressor genes. In addition, we describe the implications the changes in oncogenes and tumor suppressor genes have on designing new therapeutic strategies for the treatment of cancer.
Similar articles
-
Strategies for cancer gene therapy.J Surg Oncol. 2004 Jan;85(1):28-35. doi: 10.1002/jso.20001. J Surg Oncol. 2004. PMID: 14696084 Review.
-
MicroRNAs in human cancer: from research to therapy.J Cell Sci. 2007 Jun 1;120(Pt 11):1833-40. doi: 10.1242/jcs.03450. J Cell Sci. 2007. PMID: 17515481
-
Novel molecular and cellular strategies in cancer therapy.In Vivo. 1998 Jan-Feb;12(1):35-41. In Vivo. 1998. PMID: 9575424 Review.
-
Current strategies in cancer gene therapy.Eur J Pharmacol. 2004 Sep 13;498(1-3):1-8. doi: 10.1016/j.ejphar.2004.06.054. Eur J Pharmacol. 2004. PMID: 15363969 Review.
-
Cancer cytogenetics and molecular genetics: detection and therapeutic strategy.In Vivo. 1994 Nov-Dec;8(5):807-18. In Vivo. 1994. PMID: 7727729 Review.
Cited by
-
Gene therapy for lung cancer.Mol Biotechnol. 2003 Oct;25(2):139-48. doi: 10.1385/MB:25:2:139. Mol Biotechnol. 2003. PMID: 14526124 Review.
-
Genetic instability in cancer: caretaker and gatekeeper genes.Ochsner J. 1999 Oct;1(4):206-9. Ochsner J. 1999. PMID: 21845140 Free PMC article. No abstract available.
-
Inactivation of the p15 gene in children with acute lymphoblastic leukemia.Sao Paulo Med J. 2003 Sep 1;121(5):203-6. doi: 10.1590/s1516-31802003000500005. Epub 2003 Nov 5. Sao Paulo Med J. 2003. PMID: 14666292 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical